Toronto Dominion Bank Regeneron Pharmaceuticals, Inc. Transaction History

Toronto Dominion Bank

  • $62.8 Billion
  • Q1 2024

A detailed history of Toronto Dominion Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 62,220 shares of REGN stock, worth $63.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
62,220
Previous 61,608 0.99%
Holding current value
$63.7 Million
Previous $54.1 Million 10.68%
% of portfolio
0.1%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $552,446 - $607,930
612 Added 0.99%
62,220 $59.9 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $1.47 Million - $1.67 Million
1,892 Added 3.17%
61,608 $54.1 Million
Q3 2023

Feb 14, 2024
SELL
$692.45 - $844.37 $1.44 Million - $1.76 Million
-2,081 Reduced 3.37%
59,716 $49.1 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $1.44 Million - $1.76 Million
-2,081 Reduced 3.37%
59,716 $49.1 Million
Q2 2023

Feb 14, 2024
BUY
$700.03 - $830.35 $132,305 - $156,936
189 Added 0.31%
61,797 $44.4 Million
Q2 2023

Aug 10, 2023
BUY
$700.03 - $830.35 $1.53 Million - $1.82 Million
2,190 Added 3.67%
61,797 $44.4 Million
Q1 2023

May 11, 2023
BUY
$680.49 - $826.97 $2.78 Million - $3.37 Million
4,078 Added 7.34%
59,607 $49 Million
Q4 2022

Feb 07, 2023
BUY
$705.89 - $766.39 $5.8 Million - $6.3 Million
8,217 Added 17.37%
55,529 $40 Million
Q3 2022

Nov 09, 2022
SELL
$573.97 - $724.32 $4.74 Million - $5.98 Million
-8,254 Reduced 14.85%
47,312 $32.6 Million
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $4.33 Million - $5.83 Million
-7,889 Reduced 12.43%
55,566 $32.8 Million
Q1 2022

May 09, 2022
SELL
$595.12 - $698.43 $5.17 Million - $6.07 Million
-8,688 Reduced 12.04%
63,455 $44.3 Million
Q4 2021

Feb 04, 2022
BUY
$543.48 - $670.97 $7.99 Million - $9.86 Million
14,694 Added 25.58%
72,143 $45.6 Million
Q3 2021

Nov 08, 2021
BUY
$574.03 - $680.96 $6.43 Million - $7.63 Million
11,198 Added 24.21%
57,449 $34.8 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $21.9 Million - $25.8 Million
46,251 New
46,251 $25.8 Million

Others Institutions Holding REGN

# of Institutions
1,427
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $110B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email